MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism dementia complex(PDC)"

  • 2022 International Congress

    Lewy body disease clinical subgroups present similar disease progression rates

    C. Abdelnour, C. Young, E. Müller-Oehring, D. Ferreira, M. Shahid, M. Plastini, J. Winer, K. Poston (Stanford, USA)

    Objective: To characterize LBD clinical subgroups and identify possible differences in disease progression. Background: Patients with Lewy body disease (LBD) present a wide variety of…
  • 2022 International Congress

    The East London Parkinson Disease Project – engaging a diverse population in research

    A. Zirra, A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to engage a diverse group of people with Parkinson disease (PwP) from East London and build a research…
  • 2022 International Congress

    Plasma Alzheimer’s disease biomarkers and cognitive progression in Parkinson’s disease

    A. Pilotto, NJ. Ashton, A. Lupini, B. Battaglio, S. Gipponi, E. Cottini, I. Grossi, A. Salvi, G. de Petro, M. Pizzi, K. Blennov, M. Gonzalez, D. Aarsland, H. Zetterberg, A. Padovani (Brescia, Italy)

    Objective: To evaluate the relationship between plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease Background: Plasma phosphorylated tau (ptau) isoforms have been recently…
  • MDS Virtual Congress 2021

    Early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia: A Population-based Study (2010-2015).

    E. Camerucci, C. Stang, M. Hajeb, P. Turcano, A. Mullan, D. Jones, J. Graff-Radford, O. Ross, J. Bower, B. Boeve, R. Savica (Rochester, USA)

    Objective: To examine the incidence, clinical features, and survival of early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia (DLB/PDD) (≤55 years of age) in…
  • MDS Virtual Congress 2021

    A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson’s Disease Dementia.

    SH. Pasternak, C. Silviera, K. Coleman, E. Finger, J. Wells, M. Borrie, S. Morrow, G. Zou, R. Bartha, P. Macdonald, ME. Jenkins, M. Jog, R. Tirona, CA. Rupar (London, Canada)

    Objective: Currently there are no disease-treatments for Synucleinopathies including Parkinson’s disease dementia (PDD). Our objective is to use Ambroxol to target GBA/Glucocerebrosidase to treat PDD.…
  • MDS Virtual Congress 2021

    Exploring the Potential Anti-dementia Roles of Selected Herbal Anti-inflammatory Remedies in Parkinson’s Disease: Hopes and Challenges

    SA. Atunwa (Ilorin, Nigeria)

    Objective: To evaluate anti-dementia properties of the selected herbal anti-inflammatory remedies Background: Parkinson’s disease (PD) is the most common age-related neurodegenerative disease after Alzheimer’s disease.…
  • MDS Virtual Congress 2020

    Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia

    S. Tezcan Aydemir, M. Kuzu Kumcu, C. Akbostancı (Ankara, Turkey)

    Objective: Our focus was on comparing the performance of CDT and MMSE in Parkinson’s Disease Dementia (PDD) and Alzheimer’s Disease (AD) patients. Background: The mini…
  • MDS Virtual Congress 2020

    Clinical characteristics of pain in Parkinson’s disease dementia

    B. Ciopleias, S. Diaconu, R. Chiujdea, C. Falup-Pecurariu (Braşov, Romania)

    Objective: The aim of this study was the assess the prevalence of pain in Parkinson’s disease dementia, its clinical characteristics, and correlations with motor part…
  • MDS Virtual Congress 2020

    When and how to stop subthalamic deep brain stimulation in late-stage Parkinson’s disease

    M. Fabbri, M. Zibetti, m. Rizzone, G. Giannini, L. Borellini, A. Stefani, F. Bove, A. Bruno, G. Calandra-buonaura, N. Modugno, C. Piano, A. Peppe, G. Ardolino, A. Romagnolo, C. Artusi, P. Berchialla, E. Montanaro, P. Cortelli, L. Romito, R. Eleopra, B. Minafra, C. Pacchetti, L. Lopiano (Bologna, Italy)

    Objective: We sought to investigate the percentage of “poor stimulation responders” among late-stage Parkinson's disease (LSPD) patients for elaborating an algorithm to decide whether and…
  • MDS Virtual Congress 2020

    Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research

    L. Suttner, S. Xie (Philadelphia, PA, USA)

    Objective: To develop a quantitative method for designing appropriate longitudinal follow-up frequency. We demonstrate how to use this new method using a progression study of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley